Furthermore, the tumor suppressing function of miR-107 has been previously reported in HCC via targeting oncogenic genes, including RGS4, HMGA2, HMGCS2, cofilin-1, and Wnt/β-catenin [39–43]. This evidence concerns the gene HMGCS2 and hepatocellular carcinoma.